ClearPoint Neuro (CLPT) Competitors $11.29 +0.03 (+0.27%) Closing price 04:00 PM EasternExtended Trading$11.44 +0.15 (+1.33%) As of 07:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CLPT vs. LQDA, FNA, SSII, ESTA, PLSE, BLFS, MDXG, INMD, KMTS, and IRMDShould you be buying ClearPoint Neuro stock or one of its competitors? The main competitors of ClearPoint Neuro include Liquidia Technologies (LQDA), Paragon 28 (FNA), SS Innovations International (SSII), Establishment Labs (ESTA), Pulse Biosciences (PLSE), BioLife Solutions (BLFS), MiMedx Group (MDXG), InMode (INMD), Kestra Medical Technologies (KMTS), and iRadimed (IRMD). These companies are all part of the "medical equipment" industry. ClearPoint Neuro vs. Its Competitors Liquidia Technologies Paragon 28 SS Innovations International Establishment Labs Pulse Biosciences BioLife Solutions MiMedx Group InMode Kestra Medical Technologies iRadimed Liquidia Technologies (NASDAQ:LQDA) and ClearPoint Neuro (NASDAQ:CLPT) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, institutional ownership, analyst recommendations, profitability, risk and earnings. Which has higher earnings & valuation, LQDA or CLPT? ClearPoint Neuro has higher revenue and earnings than Liquidia Technologies. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Liquidia Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLiquidia Technologies$14M73.64-$130.39M-$1.58-7.63ClearPoint Neuro$31.39M10.07-$18.91M-$0.76-14.86 Does the media prefer LQDA or CLPT? In the previous week, Liquidia Technologies had 2 more articles in the media than ClearPoint Neuro. MarketBeat recorded 3 mentions for Liquidia Technologies and 1 mentions for ClearPoint Neuro. ClearPoint Neuro's average media sentiment score of 1.90 beat Liquidia Technologies' score of 0.71 indicating that ClearPoint Neuro is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Liquidia Technologies 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ClearPoint Neuro 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do insiders and institutionals believe in LQDA or CLPT? 64.5% of Liquidia Technologies shares are owned by institutional investors. Comparatively, 30.1% of ClearPoint Neuro shares are owned by institutional investors. 26.5% of Liquidia Technologies shares are owned by company insiders. Comparatively, 7.0% of ClearPoint Neuro shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has more risk and volatility, LQDA or CLPT? Liquidia Technologies has a beta of -0.01, meaning that its share price is 101% less volatile than the S&P 500. Comparatively, ClearPoint Neuro has a beta of 0.92, meaning that its share price is 8% less volatile than the S&P 500. Is LQDA or CLPT more profitable? ClearPoint Neuro has a net margin of -64.51% compared to Liquidia Technologies' net margin of -903.80%. ClearPoint Neuro's return on equity of -78.09% beat Liquidia Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Liquidia Technologies-903.80% -177.91% -60.15% ClearPoint Neuro -64.51%-78.09%-51.33% Do analysts rate LQDA or CLPT? Liquidia Technologies currently has a consensus target price of $26.89, indicating a potential upside of 122.96%. ClearPoint Neuro has a consensus target price of $25.00, indicating a potential upside of 121.43%. Given Liquidia Technologies' higher probable upside, equities analysts plainly believe Liquidia Technologies is more favorable than ClearPoint Neuro.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Liquidia Technologies 1 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.00ClearPoint Neuro 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryLiquidia Technologies and ClearPoint Neuro tied by winning 8 of the 16 factors compared between the two stocks. Get ClearPoint Neuro News Delivered to You Automatically Sign up to receive the latest news and ratings for CLPT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CLPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLPT vs. The Competition Export to ExcelMetricClearPoint NeuroMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$315.16M$6.89B$5.54B$8.87BDividend YieldN/A1.16%5.39%4.10%P/E Ratio-14.8626.5426.1719.90Price / Sales10.0795.96414.67113.66Price / CashN/A21.0136.1356.90Price / Book12.274.718.055.38Net Income-$18.91M$173.18M$3.15B$248.50M7 Day Performance-4.00%1.45%1.85%2.97%1 Month Performance-4.24%0.27%4.81%6.02%1 Year Performance113.02%29.02%34.86%20.39% ClearPoint Neuro Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLPTClearPoint Neuro2.2883 of 5 stars$11.29+0.3%$25.00+121.4%+111.3%$315.16M$31.39M-14.86110Positive NewsLQDALiquidia Technologies3.3726 of 5 stars$13.26+0.7%$26.89+102.8%-0.3%$1.13B$14.14M-8.3950Positive NewsFNAParagon 280.4962 of 5 stars$13.11+0.1%$12.75-2.7%+99.5%$1.10B$256.18M-17.71343,000High Trading VolumeSSIISS Innovations InternationalN/A$5.65-18.4%N/AN/A$1.09B$20.65M0.004Gap DownHigh Trading VolumeESTAEstablishment Labs1.2754 of 5 stars$36.58-3.3%$52.40+43.2%+0.1%$1.06B$166.02M-11.801,018PLSEPulse Biosciences1.3697 of 5 stars$15.49+1.2%N/A+37.0%$1.04B$700K0.00140BLFSBioLife Solutions3.0807 of 5 stars$21.36+0.7%$31.17+45.9%+4.2%$1.01B$82.25M-73.65440Positive NewsMDXGMiMedx Group3.7419 of 5 stars$5.94+2.2%$12.50+110.4%-7.2%$877.34M$348.88M22.00870INMDInMode3.3306 of 5 stars$13.49+1.6%$18.54+37.4%-17.0%$852.70M$394.82M5.79480KMTSKestra Medical TechnologiesN/A$16.00+6.5%$27.50+71.9%N/A$821.60MN/A0.00300News CoverageHigh Trading VolumeIRMDiRadimed4.691 of 5 stars$59.49+2.1%$72.00+21.0%+39.3%$756.71M$73.24M38.38110Positive News Related Companies and Tools Related Companies Liquidia Technologies Competitors Paragon 28 Competitors SS Innovations International Competitors Establishment Labs Competitors Pulse Biosciences Competitors BioLife Solutions Competitors MiMedx Group Competitors InMode Competitors Kestra Medical Technologies Competitors iRadimed Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CLPT) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ClearPoint Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ClearPoint Neuro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
